BROWSE·page 480 of 608

Browse EX-10 agreements

7,294 total material contract exhibits.


SECURED CONVERTIBLE PROMISSORY NOTE

(Additional Note #3)

DATE: May 27, 2026

BORROWERS: NKGen Biotech, Inc. and NKGen Operating Biotech, Inc., 3001 Daimler St., Santa Ana, CA 92705

LENDER: AlpineBrook Capital GP I Limited

PRINCIPAL: US$2,420,000

FOR VALUE RECEIVED, each undersigned, NKGen Biotech, Inc. (“NKGen Bio”) and NKGen Operating Biotech, Inc. (each, a “Borrower”) promises to pay to the order of AlpineBrook Capital GP I Limited (“Lender”) (i) in lawful money of the United States of America or, (ii) at the sole and absolute discretion of the Lender, in the form of newly issued shares of common stock of NKGen Bio, par value $0.0001 per share (the “Common Stock”), with applicable registration rights (the “Alternative Equity Repayment”), the principal amount of Two Million Four Hundred Twenty Thousand Dollars (US$2,420,000) or so much as may be outstanding, together with accrued interest and any other amounts

EX-10.2·8-K·CIK 1845459·ACC 0001213900-26-064294·Filed Jun 02, 2026, 17:20 ET

NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

NKGEN BIOTECH, INC.

Date of Issuance: May 27, 2026 (“Issuance Date”)

EX-10.3·8-K·CIK 1845459·ACC 0001213900-26-064294·Filed Jun 02, 2026, 17:20 ET

THIRD OMNIBUS AMENDMENT TO

SECURED CONVERTIBLE LOAN AGREEMENT AND WARRANTS

THIS THIRD OMNIBUS AMENDMENT TO SECURED CONVERTIBLE LOAN AGREEMENT AND WARRANTS (this “Amendment”) is dated as of May 27, 2026 by and among NKGEN OPERATING BIOTECH, INC., a Delaware corporation (“NKGen OpCo”), NKGEN BIOTECH, INC., a Delaware corporation (“NKGen Bio”, and collectively with NKGen OpCo, the “Borrowers”), and AlpineBrook Capital GP I Limited (“AlpineBrook” or the “Lender”, and together with the Loan Parties, the “Parties”).

EX-10.1·8-K·CIK 1845459·ACC 0001213900-26-064294·Filed Jun 02, 2026, 17:20 ET

EX-10.1

Cactus, Inc.

EXECUTION VERSION

FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

This FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Fourth Amendment”) is made and entered into as of May 29, 2026 (the “Fourth Amendment Effective Date”), by and among CACTUS COMPANIES, LLC, a Delaware limited liability company, as borrower (the “Borrower”), the other Loan Parties party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., in its capacity as administrative agent (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”). Capitalized terms used but not defined herein have the meaning set forth in the Amended Credit Agreement (as defined below).

RECITALS:

EX-10.1·8-K·CIK 1699136·ACC 0001628280-26-039880·Filed Jun 02, 2026, 17:15 ET

EX-10.1

NUCOR CORP

RETIREMENT, SEPARATION, WAIVER AND RELEASE AGREEMENT

This Retirement, Separation, Waiver and Release Agreement (“Agreement”) is entered into as of the 28th day of May, 2026, by and between David A. Sumoski (“Executive”), a citizen and resident of North Carolina, and Nucor Corporation, a Delaware corporation with its principal place of business in Charlotte, North Carolina.

WHEREAS, Executive has spent 30 years as a Nucor (as hereinafter defined) employee, and has most recently been employed as Executive Vice President of Nucor Corporation, where he was significantly involved with and responsible for the management and direction of Nucor’s business operations;

WHEREAS, Executive has decided to retire and resign from his employment with Nucor effective June 13, 2026 (the “Effective Date”);

EX-10.1·8-K/A·CIK 73309·ACC 0001193125-26-253839·Filed Jun 02, 2026, 17:11 ET

AMENDED AND RESTATED MANAGEMENT SERVICES AGREEMENT

This Management Services Agreement (together with any attachments referenced below, this “Agreement”) is made effective as of June 1, 2026 (the “Effective Date”), by and between Allarity Therapeutics, Inc. a Delaware corporation (“Company”), and Ljungaskog Consulting AB, a Swedish limited liability company (“Consultant”). Company and Consultant are also referred to as the “Parties” and each as a “Party.”

Consultant shall be further identified as follows:

Address Primary Contact Name
[*****] [*****]
Telephone Primary Contact Email
[*****] [*****]

The Parties, intending legally and equitably to be bound, agree as follows:

EX-10.1·8-K·CIK 1860657·ACC 0001213900-26-064278·Filed Jun 02, 2026, 17:10 ET

EX-10.2

Worthington Steel, Inc.

Execution Version

THIRD AMENDMENT TO REVOLVING CREDIT AND SECURITY AGREEMENT

This Third Amendment to Revolving Credit and Security Agreement (this “Amendment”) is made as of June 1, 2026, by and among WORTHINGTON STEEL, INC., an Ohio corporation (“Worthington Steel” or “Borrower”), WORTHINGTON WSP, LLC, a Michigan limited liability company (“WSP”), TEMPEL STEEL COMPANY, LLC, an Illinois limited liability company (“Tempel”), T DO B, LLC, an Illinois limited liability company (“T DO B”), TEMPEL CANADA COMPANY, a Nova Scotia company (“Tempel Canada”), TEMPEL DE MEXICO, S. DE R.L. DE C.V., a Mexican Sociedad de Responsabilidad Limitada de Capital Variable (“Tempel Mexico”), WORTHINGTON STEEL ROME, LLC, an Ohio limited liability company (“Rome”), THE WORTHINGTON STEEL COMPANY, LLC, an Ohio limited liability company (“Worthington Company”), THE WORTHINGTON STEEL COMPANY, an Ohio corporation (“Steel Company”), WORTHINGTON TAYLOR, LLC, a Michigan limited liability company

EX-10.2·8-K·CIK 1968487·ACC 0001193125-26-253821·Filed Jun 02, 2026, 17:06 ET

EX-10.1

Worthington Steel, Inc.

EXECUTION VERSION

CUSIP Number: 98210HAD4

CREDIT AGREEMENT

dated as of June 1, 2026,

by and among

WORTHINGTON STEEL, INC.,

as Borrower,

the Lenders from time to time party hereto

and

WELLS FARGO BANK, NATIONAL ASSOCIATION,

as Administrative Agent,

WELLS FARGO SECURITIES, LLC,

CITIBANK, N.A.,

PNC CAPITAL MARKETS LLC,

KEYBANC CAPITAL MARKETS INC.,

BMO CAPITAL MARKETS CORP.,

CANADIAN IMPERIAL BANK OF COMMERCE, NY BRANCH

and

HSBC SECURITIES (USA) INC.,

as Joint Lead Arrangers and Joint Bookrunners


TABLE OF CONTENTS

EX-10.1·8-K·CIK 1968487·ACC 0001193125-26-253821·Filed Jun 02, 2026, 17:06 ET

EXHIBIT 10.1

VisionWave Holdings, Inc.

📄 Scanned document · 11 pages

EX-10.1·8-K·CIK 2038439·ACC 0001731122-26-000806·Filed Jun 02, 2026, 17:01 ET

EX-10.1

Shattuck Labs, Inc.

SHATTUCK LABS, INC.

AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN

ADOPTED BY THE BOARD: SEPTEMBER 29, 2020

AMENDED AND RESTATED: MAY 28, 2026

1. GENERAL.

(a) Successor to Prior Plan. This Plan is the successor to the Shattuck Labs, Inc. 2016 Stock Incentive Plan, as amended by Amendment No. 1 thereto (the “Prior Plan”). From and after 12:01 a.m. Central time on the Effective Date, no additional stock awards will be granted under the Prior Plan. All stock awards granted under the Prior Plan prior to the Effective Date that remain outstanding on the Effective Date shall be cancelled and replaced with equivalent Awards under this Plan. All Awards granted on or after 12:01 a.m. Eastern Time on the Effective Date are subject to the terms of this Plan.

(b) Eligible Award Recipients. Employees, Directors and Consultants are eligible to receive Awards.

EX-10.1·8-K·CIK 1680367·ACC 0001193125-26-253784·Filed Jun 02, 2026, 17:00 ET

PRE-PAID PURCHASE #2

June 2, 2026 U.S. $6,480,000.00

FOR VALUE RECEIVED, SOLOWIN HOLDINGS, an exempted company incorporated under the laws of the Cayman Islands with limited liability (“Company”), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“Investor”), $6,480,000.00 and any interest, fees, charges, and late fees accrued hereunder in accordance with the terms set forth herein and to pay interest on the Outstanding Balance at the rate of eight percent (8%) per annum simple interest from the Purchase Price Date until the same is paid in full. All interest calculations hereunder shall be computed on the basis of a 360-day year comprised of twelve (12) thirty (30) day months and shall be payable in accordance with the terms of this Pre-Paid Purchase #2 (this “Pre-Paid Purchase”), which is issued and made effective as of the date set forth above (the “Effective Date”). This Pre-Paid Purchase is issued pursuant to that certain Securities Purchase Agreement

EX-10.1·6-K·CIK 1959224·ACC 0001213900-26-064255·Filed Jun 02, 2026, 17:00 ET

STREETERVILLE CAPITAL, LLC

June 2, 2026

Solowin Holdings

Attn: Ling Ngai Lok

Room 1910-1912A, Tower 3, China Hong Kong City

33 Canton Road, Tsim Sha Tsui, Kowloon

Hong Kong

Re: Funding of Additional Pre-Paid Purchase

Dear Mr. Lok:

This letter agreement (this “Letter Agreement”) is entered into by and between Streeterville Capital, LLC, a Utah limited liability company (“Investor”), and Solowin Holdings, an exempted company incorporated under the laws of the Cayman Islands with limited liability (“Company”), in connection with that certain Securities Purchase Agreement dated February 9, 2026 between Company and Investor (the “Purchase Agreement”). Company has requested that Investor fund $6,000,000.00 for the purchase of Pre-Paid Purchase #2 (“PPP #2”) pursuant to the Purchase Agreement. The Company hereby agrees to sell, issue and deliver to Investor 1,000,000 Class A Shares (as defined in the Purchase Agreement) for a purchase price of $0.0001 per share (the “Additional Pre-Delivery Shares”)

EX-10.2·6-K·CIK 1959224·ACC 0001213900-26-064255·Filed Jun 02, 2026, 17:00 ET